Dr. Arvind Kumar, MD

Dr. Kumar practices at Fayetteville Gastroenterology Associates, P.a. in Fayetteville, North Carolina.

Dr. Kumar's NPI, 1508882325, was assigned on July 14, 2006. Dr. Kumar holds North Carolina license 200000500.

Dr. Kumar's primary practice is Fayetteville Gastroenterology Associates, P.a., at 2041 Valleygate Dr, Fayetteville, NC 28304. The practice phone is (910) 323-5203.

Dr. Kumar's primary practice is Fayetteville Gastroenterology Associates, P.a. in Fayetteville, North Carolina. Dr. Kumar is also affiliated with Cape Fear Valley Medical Center. The medical group on file is Cape Fear Valley Interventional Radiology. Dmand AI also links Dr. Kumar to 3 more group practices and clinics and 3 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 5 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Kumar is licensed in North Carolina.

CMS data shows 2,007 Medicare services from Dr. Kumar across 17 procedure codes in 2024, for 787 Medicare patients. Medicare paid $163,852 for them.

CMS counts 787 Medicare patients who saw Dr. Kumar in 2024. The largest group is 65 to 74, with 410 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 10% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 66, with 65% women.

In 2024, Dr. Kumar wrote 611 Medicare Part D claims for 242 patients. 85% of them were for generic drugs. CMS names the drug for 449 of them, across 10 drugs with 11 or more claims each, at $59,421 in total drug cost. In 2023, CMS named 515 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kumar for performance year 2024, reported as part of a group. Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 171 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Kumar, more than 87% of the clinicians it reports for that procedure.

Dmand AI links 938 papers to Dr. Kumar, published from 2009 to 2025. 2021 was the busiest year, with 103. The most frequent topics are India, Oryza and Quantitative Trait Loci. Dr. Kumar has published most often in Cureus. Dr. Kumar's most frequent co-authors are Rizwan Khan, DO, Anjan Trikha, MD and Mark Francis Berry, MD.

Dmand AI links Dr. Kumar to 1 clinical trial. Conditions studied include Non-alcoholic Fatty Liver Disease and Fatty Liver.

CMS Open Payments shows 278 general payments to Dr. Kumar from 40 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Abbvie Inc. paid the most, $1,931.